Table of contents
Gout
What's new
Updated 2024 EULAR guidelines for the diagnosis of crystal arthropathies.
Background
Overview
Definition
Gout is a type of inflammatory arthritis characterized by the deposition of monosodium urate monohydrate crystals in synovial fluid and other tissues.
1
Pathophysiology
Gout is due to persistently elevated blood levels of uric acid (hyperuricemia), which is often multifactorial (increased intake of purine-rich foods, defects in purine metabolism, older age, male sex, obesity, renal failure, diuretics).
2
Epidemiology
In the US, the prevalence of gout is estimated at 3,900 persons per 100,000 population. The incidence of gout is estimated at 400 per 100,000 person-years in men, and 140 per 100,000 person-years in women.
3
4
Disease course
In patients with acute gout, deposition of urate monohydrate crystals inside joint cavities initiate an inflammatory response that results in the clinical manifestations of arthritis. Chronic synovitis, bony erosions, cartilage damage, and tophi formation may occur in patients with chronic gout.
2
Prognosis and risk of recurrence
The 1-year recurrence rate for acute gout attack in patients who have experienced an attack in the past year is estimated at 69%.
1
Guidelines
Key sources
The following summarized guidelines for the evaluation and management of gout are prepared by our editorial team based on guidelines from the European League Against Rheumatism (EULAR 2024,2023,2020,2017), the American College of Rheumatology (ACR 2023,2020,2012), the American College of Physicians (ACP 2017), the American College of Radiology (ACR 2017), the British Society for Rheumatology (BSR 2017), the Treat-to-target (T2T 2017), ...
Show more
Screening and diagnosis
Diagnostic investigations
Clinical evaluation: as per EULAR 2020 guidelines, assess for risk factors for chronic hyperuricemia in all patients with gout, specifically CKD, overweight, medications (including diuretics, low-dose aspirin, cyclosporine, tacrolimus), consumption of excess alcohol (particularly beer and spirits), non-diet sodas, meat and shellfish.
A
More topics in this section
Diagnostic imaging
Genetic testing
Evaluation for comorbidities
Screening for chronic infections
Diagnostic procedures
Synovial fluid analysis, indications: as per EULAR 2024 guidelines, do not perform synovial fluid analysis to confirm the diagnosis when characteristic features of monosodium urate crystal deposition on ultrasound (double contour sign or tophi) or dual-energy CT are identified.
D
More topics in this section
Synovial fluid analysis (technical considerations)
Medical management
Management of acute flares: as per ACR 2020 guidelines, initiate concomitant anti-inflammatory prophylaxis therapy (such as colchicine, NSAIDs, prednisone/prednisolone) in patients with gout. Select the specific agent of anti-inflammatory prophylaxis based on patient factors.
B
Show 5 more
More topics in this section
Indications for urate-lowering therapy
Treatment targets
Allopurinol
Xanthine oxidase inhibitors
Uricosuric therapy
Pegloticase
Anti-inflammatory therapy
Nonpharmacologic interventions
Discontinuation of contributing medications: as per ACR 2012 guidelines, discontinue non-essential medications that are associated with elevation in serum urate levels (such as thiazide diuretics, loop diuretics, niacin, and calcineurin inhibitors).
B
More topics in this section
Rest and ice packs
Dietary modifications
Weight loss
Exercise
Alcohol intake
Vitamin C
Specific circumstances
HLA-B*58:01 allele carriers: as per CPIC 2013 guidelines, do not use allopurinol in HLA-B58:01 allele carriers.
D
More topics in this section
Patients taking antihypertensive medications
Patients taking aspirin
Patients taking fenofibrate
Patient education
Preventative measures
Routine immunizations: as per ACR 2023 guidelines, consider offering high-dose or adjuvanted influenza vaccination, rather than regular-dose influenza vaccination, in ≥ 65 years old patients with rheumatic or musculoskeletal diseases and in 18-65 years old patients with rheumatic or musculoskeletal diseases on immunosuppressive medications.
C
Show 17 more
More topics in this section
Prophylaxis for P. jirovecii pneumonia
Follow-up and surveillance
Indications for specialist referral: as per ACR 2012 guidelines, refer patients for specialist consultation in the following situations:
unclear etiology of hyperuricemia
refractory signs or symptoms of gout
difficulty in reaching the target serum urate level, particularly with renal impairment and a trial of xanthine oxidase inhibitor treatment
multiple and/or serious adverse events from pharmacologic urate-lowering therapy.
B
More topics in this section
Serum urate monitoring
Imaging follow-up
Indications for switching urate-lowering agents
Management of refractory disease